LET’S END THIS TOGETHER

Shoreside Laboratory COVID-19 Screening

You Cannot Afford to Have Your Cruise Line Shutdown Again

The COVID-19 pandemic has sidelined the cruise industry. After being shut down for over a year, ships will be able to finally sail again in the near future. In their conditional COVID-19 sailing order for cruise ships issued in May 2021, the CDC requires passengers and crew to be tested for COVID-19 shoreside using a sensitive Nucleic Acid Amplification Tests (NAATs) that has been authorized for emergency use by the FDA1. Cruise lines will leverage vaccinations and COVID-19 testing to increase the safety of their passengers and staff.

PerkinElmer can help you you meet the CDC testing requirements for shoreside laboratory COVID-19 screening1.

A sensitive COVID-19 NAAT for shoreside cruise ship testing

The PerkinElmer New Coronavirus Nucleic Acid Detection Kit is the most sensitive commercially available COVID-19 molecular diagnostic test authorized for emergency use, as reported by FDA’s reference panel study2. A 10-fold increase in LOD above PerkinElmer’s test can increase false negative rate by 13%3.

PerkinElmer, Inc. is one of a few entities that manufactures a molecular diagnostic test kit authorized by the FDA to screen pooled asymptomatic individuals4 – this capability can reduce the cost and increase the throughput of COVID-19 testing.

Screen pooled asymptomatic individuals for shoreside cruise ship testing
Pooling reduces costs for shoreside cruise ship testing
Contact your PerkinElmer representative today to ensure you offer sensitive onshore COVID-19 testing as reccomended by the CDC.

For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.